Circular dichroism study of DNA binding by a potential anticancer peptide nucleic acid targeted against the MYCN

Andrea Faccini1, Andrea Tortori, Tullia Tedeschi

  • 1Dipartimento di Chimica, Organica e Industriale, Università di Parma, Parma, Italy.

Chirality
|October 27, 2007
PubMed

Insights

This study shows that a peptide nucleic acid (PNA) with a nuclear localization signal (NLS) forms highly stable DNA duplexes, supporting its potential as an antitumor agent by targeting the MYCN oncogene.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Genetics

Background:

  • Peptide nucleic acid (PNA) oligomers conjugated with nuclear localization signal (NLS) peptides can inhibit tumor cell proliferation.
  • This inhibition is achieved by blocking the transcription of the MYCN oncogene.

Purpose of the Study:

  • To investigate the interaction between a PNA-NLS oligomer and DNA.
  • To characterize the stability and structure of the resulting PNA:DNA complexes.
  • To evaluate the role of the NLS peptide in complex formation and stability.

Main Methods:

  • UV and Circular Dichroism (CD) spectroscopy were employed to study PNA:DNA interactions.
  • The stability of PNA:DNA duplexes was assessed using melting temperature (Tm) measurements.
  • Competition experiments were conducted to investigate complex formation in the presence of double-stranded DNA (dsDNA).

Main Results:

  • CD spectroscopy provided clear evidence for the formation of exceptionally stable PNA:DNA duplexes (Tm >= 90°C).
  • Mutational effects on DNA:PNA stability were consistent with Watson-Crick base pairing.
  • PNA lacking the NLS peptide formed less stable duplexes, indicating the NLS peptide enhances stability.
  • Competition experiments suggested the formation of a ternary complex at 25°C, dissociating into PNA:DNA duplex and displaced DNA at higher temperatures.

Conclusions:

  • The PNA-NLS oligomer forms highly stable DNA duplexes, indicating strong binding affinity.
  • The NLS peptide plays a crucial role in stabilizing the PNA:DNA interaction.
  • These findings support a potential in vivo mechanism of action for this antitumor PNA targeting the MYCN oncogene.